3 active not recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 3 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Practice Guidelines as Topic: new trials by email Literature Review of Practice Guidelines as Topic trials Research Report on Practice Guidelines as Topic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone Best Practice, Quality-of-Life Assessment, Questionnaire Administration - Hypogonadism, Malignant Urinary System Neoplasm | Phase 1 | Active not recruiting | Emory University | 56 | 2021-01-25 | 2026-05-26 |
| Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia Best Practice, Mesenchymal Stem Cell - COVID-19 Infection, COVID-19-Associated Acute Respiratory Distress Syndrome | Phase 1 / Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 65 | 2020-07-29 | 2026-10-05 |
| CBM588 in Improving Clinical Outcomes in Patients Who Have Undergone Donor Hematopoietic Stem Cell Transplant Best Practice, Clostridium butyricum CBM 588 Probiotic Strain - Hematopoietic and Lymphoid Cell Neoplasm | Phase 1 | Active not recruiting | City of Hope Medical Center | 36 | 2019-06-17 | 2026-10-15 |
Hematologic Neoplasms (2) · COVID-19 (1) · Hypogonadism (1) · Urologic Diseases (1) · Urologic Neoplasms (1)
City of Hope Medical Center (1) · Emory University (1) · M.D. Anderson Cancer Center (1)
United States (3)
Amanda Olson (1) · Kenneth Ogan, MD (1) · Ryotaro Nakamura (1)
P30CA138292 (1)